These effects of the R-Tf-D-LP4 peptide could be due to general elimination of the steatosis/NASH pathologies in the liver, reducing fat accumulation in hepatic cells, lowering inflammation, reducing gluconeogenesis, and increasing glycogen synthesis [23]. This evidence concerns the gene TF and steatosis.